scispace - formally typeset
U

Uma Banerjee

Researcher at All India Institute of Medical Sciences

Publications -  34
Citations -  1111

Uma Banerjee is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: Cryptococcosis & Cryptococcus neoformans. The author has an hindex of 17, co-authored 30 publications receiving 1067 citations.

Papers
More filters
Journal ArticleDOI

Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status.

TL;DR: There seems to be a significant link between hyperglycaemia and vulvo-vaginal candidiasis in diabetics with diabetes mellitus and healthy controls.
Journal ArticleDOI

Epidemiology of candidemia in a tertiary care centre of north India: 5-year study.

TL;DR: A retrospective study on the distribution of species of Candida and the risk factors associated with candidemia in Indian population for which 5 years was conducted, results were comparable to those derived from other regions of India.
Journal ArticleDOI

Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy

TL;DR: Overall only one third of patients with diabetes mellitus and VVC respond to single dose 150 mg of fluconazole therapy, which is explained by the high prevalence of C. glabrata infection.
Journal ArticleDOI

Molecular Epidemiology of Clinical Cryptococcus neoformans Strains from India

TL;DR: Differences in genetic diversity of C. neoformans isolates from India compared to isolate from other regions in the world are demonstrated and it is demonstrated that DNA typing with the TCN-1 probe can adequately distinguish C.Neoformans var.
Journal ArticleDOI

Prevalence of Candida glabrata and Its Response to Boric Acid Vaginal Suppositories in Comparison With Oral Fluconazole in Patients With Diabetes and Vulvovaginal Candidiasis

TL;DR: In this paper, the response to oral fluconazole and boric acid vaginal suppositories in diabetic patients with VVC was evaluated and the secondary outcomes were the mycological cure in C. glabrata VVC in the two treatment arms.